Personalis (PSNL) Competitors $3.47 +0.09 (+2.66%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PSNL vs. MGNX, CSTL, AGL, INNV, GRAL, FLGT, SHCR, AUNA, CELC, and DCGOShould you be buying Personalis stock or one of its competitors? The main competitors of Personalis include MacroGenics (MGNX), Castle Biosciences (CSTL), agilon health (AGL), InnovAge (INNV), Grail (GRAL), Fulgent Genetics (FLGT), Sharecare (SHCR), Auna (AUNA), Celcuity (CELC), and DocGo (DCGO). These companies are all part of the "medical" sector. Personalis vs. MacroGenics Castle Biosciences agilon health InnovAge Grail Fulgent Genetics Sharecare Auna Celcuity DocGo MacroGenics (NASDAQ:MGNX) and Personalis (NASDAQ:PSNL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership. Which has more risk & volatility, MGNX or PSNL? MacroGenics has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500. Comparatively, Personalis has a beta of 1.94, meaning that its share price is 94% more volatile than the S&P 500. Does the MarketBeat Community prefer MGNX or PSNL? MacroGenics received 311 more outperform votes than Personalis when rated by MarketBeat users. However, 66.47% of users gave Personalis an outperform vote while only 62.28% of users gave MacroGenics an outperform vote. CompanyUnderperformOutperformMacroGenicsOutperform Votes42662.28% Underperform Votes25837.72% PersonalisOutperform Votes11566.47% Underperform Votes5833.53% Which has preferable valuation and earnings, MGNX or PSNL? MacroGenics has higher earnings, but lower revenue than Personalis. Personalis is trading at a lower price-to-earnings ratio than MacroGenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMacroGenics$58.75M3.46-$9.06M-$1.58-2.05Personalis$87.49M2.80-$108.30M-$1.68-2.07 Does the media refer more to MGNX or PSNL? In the previous week, Personalis had 2 more articles in the media than MacroGenics. MarketBeat recorded 5 mentions for Personalis and 3 mentions for MacroGenics. MacroGenics' average media sentiment score of 0.64 beat Personalis' score of 0.07 indicating that MacroGenics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MacroGenics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Personalis 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate MGNX or PSNL? MacroGenics presently has a consensus target price of $7.63, indicating a potential upside of 135.34%. Personalis has a consensus target price of $6.81, indicating a potential upside of 96.33%. Given MacroGenics' higher probable upside, research analysts plainly believe MacroGenics is more favorable than Personalis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MacroGenics 0 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.36Personalis 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in MGNX or PSNL? 96.9% of MacroGenics shares are held by institutional investors. Comparatively, 61.9% of Personalis shares are held by institutional investors. 11.3% of MacroGenics shares are held by insiders. Comparatively, 4.1% of Personalis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is MGNX or PSNL more profitable? MacroGenics has a net margin of -69.07% compared to Personalis' net margin of -104.52%. Personalis' return on equity of -66.07% beat MacroGenics' return on equity.Company Net Margins Return on Equity Return on Assets MacroGenics-69.07% -89.42% -38.57% Personalis -104.52%-66.07%-41.34% SummaryMacroGenics beats Personalis on 13 of the 19 factors compared between the two stocks. Ad Brownstone ResearchBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PSNL vs. The Competition Export to ExcelMetricPersonalisMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$245.15M$3.01B$5.38B$8.84BDividend YieldN/A11.19%5.11%4.09%P/E Ratio-2.0716.90105.9717.81Price / Sales2.80213.471,247.60162.50Price / CashN/A406.7840.2336.29Price / Book1.473.217.076.50Net Income-$108.30M-$32.86M$119.40M$226.10M7 Day Performance-10.80%6.26%2.16%3.98%1 Month Performance-26.17%1.78%-3.12%3.79%1 Year Performance153.28%27.39%33.73%29.31% Personalis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PSNLPersonalis4.2098 of 5 stars$3.47+2.7%$6.81+96.3%+153.3%$245.15M$87.49M-2.07400MGNXMacroGenics3.8584 of 5 stars$3.19-0.6%$7.63+139.0%-56.2%$200.20M$58.75M-2.02430CSTLCastle Biosciences3.3866 of 5 stars$28.80-0.3%$37.88+31.5%+50.2%$806.69M$219.79M144.41540Insider TradeAGLagilon health2.2739 of 5 stars$1.75-1.7%$6.05+245.7%-84.0%$721.04M$4.32B-1.891,117Analyst ForecastINNVInnovAge1.4796 of 5 stars$4.69+1.3%$6.50+38.6%-11.7%$635.31M$763.85M-37.922,350GRALGrail0.3082 of 5 stars$16.13-1.5%N/AN/A$541.97MN/A0.001,360Insider TradeFLGTFulgent Genetics4.2609 of 5 stars$17.53+3.4%$28.50+62.6%-35.0%$536.19M$277.76M-3.091,184Analyst UpgradeSHCRSharecareN/A$1.43flat$1.43N/A$531.79M$445.25M-3.673,352AUNAAuna3.8446 of 5 stars$6.93-2.7%$13.40+93.4%N/A$512.27M$1.04B0.0014,958News CoverageCELCCelcuity2.1524 of 5 stars$12.76-0.2%$29.17+128.5%-0.2%$473.85MN/A-4.8940DCGODocGo1.6743 of 5 stars$4.24+2.9%$6.10+43.9%-26.1%$432.69M$624.29M14.754,164 Related Companies and Tools Related Companies MGNX Competitors CSTL Competitors AGL Competitors INNV Competitors GRAL Competitors FLGT Competitors SHCR Competitors AUNA Competitors CELC Competitors DCGO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PSNL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSNL Stock Alerts